- Raised $500k funding round, Oct 2024
- Raised $1.4M funding round, Jan 2023
- Raised grant led by European Union’s EIC Fund, Mar 2025
About
Magneto is developing innovative thrombectomy solutions for the removal of blood clots in the vascular system.
The Magneto catheters use electric fields to create an attraction with the target clot. When voltage is applied, the negatively charged ions of the clot are bonded to the active positive electrode of the catheter, creating a strong magnetic type of grip. This allows for clot removal without damaging the endoluminal surface of the vessel while lessening the chance of distal embolization. The fibrin content of a blood clot possesses high charge electrical density enabling strong adherence. Magneto's technology has been proven to be effective for all clot types - from acute- soft, red, Red Blood Cell-rich clots to chronic- firm, white, fibrin-rich clots. In-vitro tests have shown success in addressing a wide range of clot types with this proprietary technology.
The eTrieve™ PE kit is custom designed for the pulmonary arteries. Using Magneto's large bore aspiration catheter, together with the eTrieve™ Catheter with its proprietary electric attachment technology, the system can remove both proximal and distal emboli with minimal artery interaction and less fragmentation.
The company has demonstrated the safety and efficacy of its eTrieve PE Kit with its successful first-in-human (FIH) study. The results showed a significant reduction in right ventricular to left ventricular diameter (RV/LV) ratio and alleviation of symptoms associated with PE.
Funding history · 5 rounds · $1.9M total
Q&A
- What is Magneto Thrombectomy Solutions' primary focus?
- Magneto Thrombectomy Solutions is developing innovative thrombectomy solutions for the removal of blood clots in the vascular system, utilizing electric fields to create an attraction with the target clot.
- When was Magneto Thrombectomy Solutions founded?
- Magneto Thrombectomy Solutions was founded in May 2016.
- What is the employee count for Magneto Thrombectomy Solutions?
- Magneto Thrombectomy Solutions has 1-10 employees.
- Which investor participated in Magneto Thrombectomy Solutions' funding round in October 2024?
- Peregrine Ventures participated in Magneto Thrombectomy Solutions' funding round in October 2024, which raised $500,000.
- What is the eTrieve™ PE kit designed for?
- The eTrieve™ PE kit from Magneto Thrombectomy Solutions is custom designed for the pulmonary arteries, using a large bore aspiration catheter and proprietary electric attachment technology to remove both proximal and distal emboli.
- What was the outcome of Magneto Thrombectomy Solutions' first-in-human (FIH) study for its eTrieve PE Kit?
- The first-in-human (FIH) study for Magneto Thrombectomy Solutions' eTrieve PE Kit demonstrated safety and efficacy, showing a significant reduction in right ventricular to left ventricular diameter (RV/LV) ratio and alleviation of symptoms associated with PE.
- Which investor participated in Magneto Thrombectomy Solutions' funding round in January 2023?
- Peregrine Ventures participated in Magneto Thrombectomy Solutions' funding round in January 2023, which raised $1,350,000.
- What type of funding did Magneto Thrombectomy Solutions receive in March 2025?
- In March 2025, Magneto Thrombectomy Solutions received a Grant from the European Union’s EIC Fund.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | magts.com |
|---|---|
| linkedin.com/company/19169146 |
Identifiers & details
| Founded | 2016-5 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 10 |
|---|
Web history (Wayback)
| Domain | magts.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|